Mastercard announced that its Chief Financial Officer, Sachin Mehra, has informed the Mastercard Board of directors and his colleagues that he will be undergoing treatment for non-Hodgkin lymphoma.  It was detected very early, with scans and biopsies indicating it is highly localised and curable. With the recommended treatment, Sachin’s long-term prognosis is excellent. He will remain actively involved in daily operations, working remotely for the coming months.